All updated as on -
The injection pen market is expected to expand from its 2023 valuation of $43.32B to a whopping $74.14B by 2031, a CAGR (compound annual growth rate) of 8.5% from 2024 to 2031. Key market drivers supporting market expansion include the increasing requirement for injectable pen technologies to serve the growing patient pool and promote treatment adherence.
In recent years, there has been a dramatic rise in the incidence of chronic diseases. Subcutaneous medication injections are necessary on a daily or weekly basis for the treatment of some diseases, including diabetes, osteoporosis, cardiovascular disease (CVD), and multiple sclerosis. Because of the high frequency of drug administration, injector pens are the best solution for chronic disorders. As far as injectable medication delivery technologies go, injection pens are now the gold standard. Due to their dependability, ease of use, and capacity to be self-administered by patients, their popularity has skyrocketed. There has been a shift in emphasis toward injection pen technologies as a means to manage the increasing number of patients and improve treatment adherence in response to the rising incidence of chronic diseases. The frequency of chronic diseases is highlighted in the following important data.
Injection pen devices have various alternatives. Fear of needle sticks and the associated risks are the primary obstacles to the widespread use of injection pens. As a result, there are a number of needle-free devices available, and one of its benefits is that they do not cause needle fear, a major obstacle to the widespread use of injectable medication therapies. The discomfort of daily injections and the need for long-term treatment are the main causes of non-complacence in both children and adults. Due to the lack of dosing control, insulin pen therapy is also known to induce hyperglycemia in certain patients. The capacity of insulin pumps to automate insulin suspension and reduce the risk of hypoglycemia has led to a change in diabetes therapy away from insulin pens in Europe. Because it is safe, easy to administer, affordable, and widely accepted, oral insulin delivery is the favored method in developing nations like Brazil, India, and China.
A combination of reasons, including a larger elderly population and a rise in the incidence of chronic diseases like diabetes and cancer, is propelling the injection pen industry forward. For example, almost 537 million persons (aged 20–79) are dealing with diabetes, as stated in a report released by the International Diabetes Federation in 2021. By 2031, the predicted total number of individuals living with diabetes will reach 643 million, and by 2045, it will reach 783 million. Among adults with diabetes, about half (240 million) go undiagnosed. Furthermore, 541 million adults are at a higher risk of acquiring type 2 diabetes, and over 1.2 million children and adolescents (aged 0–19) are dealing with type 1 diabetes. An increase in the number of people living with chronic conditions and a greater understanding of the benefits of self-injectable devices are the main forces propelling the injection pen market forward.
Additionally, the main driver of market expansion is the increasing number of diabetic patients who are opting for technologically improved reusable injection pens. As an example, the InPen, a reusable smart injection pen for diabetics, was introduced by Medtronic Plc in 2020. In order to determine insulin dosages and meal carb estimates, the pen makes use of Bluetooth technology.
The market share of injection pens is also growing due to the rising popularity of automated injection pens. Because of the ease, precision, and security they provide to medication administration, automated injection pens are quickly becoming a favorite among medical professionals. The fast aging of the global population, making them more vulnerable to chronic diseases like diabetes and cancer, is driving up demand for injectable pens worldwide, not just in rich nations. These are the driving forces behind the market's expansion.
As painlessly and conveniently as possible, drugs should be injected into the body utilizing injection pens. For a wide variety of medical issues, this tiny, handheld gadget can administer precise doses of medication. The predicted growth in the prevalence of chronic disorders, such as diabetes and osteoporosis, is expected to drive up the value of the injection pen market throughout the projected period. As an example, in 2015, 39.3 million Americans, or 9.4 percent of the total population, were diagnosed with diabetes, as reported by the American Diabetes Association.
One more thing that's pushing the market up is how much more popular injectable pens are becoming compared to the old-fashioned vial and needle method. A growing number of people are dealing with long-term health issues. Patients with diabetes, cardiovascular disease, osteoporosis, or multiple sclerosis must inject themselves either daily or monthly. If you have a chronic ailment that needs your medication administered frequently, an injector pen is the way to go. One more option for injectable medicine administration is the needle-free injection pen. Their growing popularity is attributable to the fact that they are easy to use and can be administered by anybody, including those without medical training. As the number of people living with chronic illnesses continues to rise, there has been a surge in interest in injectable pen technologies as a means to better manage this expanding patient population and promote treatment adherence.
Report Coverage
Global Injection Pen research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Injection Pen report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Injection Pen competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Injection Pen market players and analyses their core competencies in each global market sub-segments.
Key Points Covered in the Report
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Injection Pen market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Injection Pen market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
Novo Nordisk A/S (Denmark), Becton, Dickinson and Company (US), Ypsomed Holding AG (Switzerland), Sanofi (France), Eli Lilly and Company (US), Merck KGaA (Germany), AstraZeneca plc (UK), F. Hoffmann-La Roche Ltd. (Switzerland), Owen Mumford (UK), Sulzer Ltd. (Switzerland), Sun Pharmaceutical Industries Ltd. (India), Pfizer (US), Biocon Ltd. (India), Lupin Ltd. (India), Wockhardt Ltd. (India), AptarGroup, Inc. (US), Novartis AG (Switzerland), Gerresheimer AG (Germany), Bespak Europe Ltd. (UK), SHL Medical AG (Switzerland), Boehringer Ingelhem (Germany), Nemera France SA, Companion Medical (US), and Jiangsu Delfu Medical Devices Co., Ltd. (China).
Primary Target Market
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2031. INFINITIVE DATA EXPERT has segmented the global Injection Pen market based on the below-mentioned segments:
Global Injection Pen Market, By Type
Disposable injection pen
Reusable injection pen
Global Injection Pen market, By Therapy
Growth Hormone
Osteoporosis
Fertility
Others
Diabetes
Global Injection Pen Market, By End User
Home-care Settings
Hospital and clinics
Global Injection Pen market, Regional Analysis
In recent years, there has been a dramatic rise in the incidence of chronic diseases. Subcutaneous medication injections are necessary on a daily or weekly basis for the treatment of some diseases, including diabetes, osteoporosis, cardiovascular disease (CVD), and multiple sclerosis. Because of the high frequency of drug administration, injector pens are the best solution for chronic disorders. As far as injectable medication delivery technologies go, injection pens are now the gold standard. Due to their dependability, ease of use, and capacity to be self-administered by patients, their popularity has skyrocketed. There has been a shift in emphasis toward injection pen technologies as a means to manage the increasing number of patients and improve treatment adherence in response to the rising incidence of chronic diseases. The frequency of chronic diseases is highlighted in the following important data.
Injection pen devices have various alternatives. Fear of needle sticks and the associated risks are the primary obstacles to the widespread use of injection pens. As a result, there are a number of needle-free devices available, and one of its benefits is that they do not cause needle fear, a major obstacle to the widespread use of injectable medication therapies. The discomfort of daily injections and the need for long-term treatment are the main causes of non-complacence in both children and adults. Due to the lack of dosing control, insulin pen therapy is also known to induce hyperglycemia in certain patients. The capacity of insulin pumps to automate insulin suspension and reduce the risk of hypoglycemia has led to a change in diabetes therapy away from insulin pens in Europe. Because it is safe, easy to administer, affordable, and widely accepted, oral insulin delivery is the favored method in developing nations like Brazil, India, and China.
A combination of reasons, including a larger elderly population and a rise in the incidence of chronic diseases like diabetes and cancer, is propelling the injection pen industry forward. For example, almost 537 million persons (aged 20–79) are dealing with diabetes, as stated in a report released by the International Diabetes Federation in 2021. By 2031, the predicted total number of individuals living with diabetes will reach 643 million, and by 2045, it will reach 783 million. Among adults with diabetes, about half (240 million) go undiagnosed. Furthermore, 541 million adults are at a higher risk of acquiring type 2 diabetes, and over 1.2 million children and adolescents (aged 0–19) are dealing with type 1 diabetes. An increase in the number of people living with chronic conditions and a greater understanding of the benefits of self-injectable devices are the main forces propelling the injection pen market forward.
Additionally, the main driver of market expansion is the increasing number of diabetic patients who are opting for technologically improved reusable injection pens. As an example, the InPen, a reusable smart injection pen for diabetics, was introduced by Medtronic Plc in 2020. In order to determine insulin dosages and meal carb estimates, the pen makes use of Bluetooth technology.
The market share of injection pens is also growing due to the rising popularity of automated injection pens. Because of the ease, precision, and security they provide to medication administration, automated injection pens are quickly becoming a favorite among medical professionals. The fast aging of the global population, making them more vulnerable to chronic diseases like diabetes and cancer, is driving up demand for injectable pens worldwide, not just in rich nations. These are the driving forces behind the market's expansion.
As painlessly and conveniently as possible, drugs should be injected into the body utilizing injection pens. For a wide variety of medical issues, this tiny, handheld gadget can administer precise doses of medication. The predicted growth in the prevalence of chronic disorders, such as diabetes and osteoporosis, is expected to drive up the value of the injection pen market throughout the projected period. As an example, in 2015, 39.3 million Americans, or 9.4 percent of the total population, were diagnosed with diabetes, as reported by the American Diabetes Association.
One more thing that's pushing the market up is how much more popular injectable pens are becoming compared to the old-fashioned vial and needle method. A growing number of people are dealing with long-term health issues. Patients with diabetes, cardiovascular disease, osteoporosis, or multiple sclerosis must inject themselves either daily or monthly. If you have a chronic ailment that needs your medication administered frequently, an injector pen is the way to go. One more option for injectable medicine administration is the needle-free injection pen. Their growing popularity is attributable to the fact that they are easy to use and can be administered by anybody, including those without medical training. As the number of people living with chronic illnesses continues to rise, there has been a surge in interest in injectable pen technologies as a means to better manage this expanding patient population and promote treatment adherence.
Report Coverage
Global Injection Pen research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Injection Pen report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Injection Pen competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Injection Pen market players and analyses their core competencies in each global market sub-segments.
| REPORT ATTRIBUTES | DETAILS |
|---|---|
| Study Period | 2017-2031 |
| Base Year | 2023 |
| Forecast Period | 2023-2031 |
| Historical Period | 2017-2021 |
| Unit | Value (USD Billion) |
| Key Companies Profiled | Novo Nordisk A/S (Denmark), Becton, Dickinson and Company (US), Ypsomed Holding AG (Switzerland), Sanofi (France), Eli Lilly and Company (US), Merck KGaA (Germany), AstraZeneca plc (UK), F. Hoffmann-La Roche Ltd. (Switzerland), Owen Mumford (UK), Sulzer Ltd. (Switzerland), Sun Pharmaceutical Industries Ltd. (India), Pfizer (US), Biocon Ltd. (India), Lupin Ltd. (India), Wockhardt Ltd. (India), AptarGroup, Inc. (US), Novartis AG (Switzerland), Gerresheimer AG (Germany), Bespak Europe Ltd. (UK), SHL Medical AG (Switzerland), Boehringer Ingelhem (Germany), Nemera France SA, Companion Medical (US), and Jiangsu Delfu Medical Devices Co., Ltd. (China). |
| Segments Covered | • By Product |
| Customization Scope | Free report customization (equivalent to up to 3 analyst working days) with purchase. Addition or alteration to country, regional & segment scope |
Key Points Covered in the Report
- Market Revenue of Injection Pen Market from 2021 to 2031.
- Market Forecast for Injection Pen Market from 2021 to 2031.
- Regional Market Share and Revenue from 2021 to 2031.
- Country Market share within region from 2021 to 2031.
- Key Type and Application Revenue and forecast.
- Company Market Share Analysis, Injection Pen competitive scenario, ranking, and detailed company
profiles. - Market driver, restraints, and detailed COVID-19 impact on Injection Pen
Market
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Injection Pen market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Injection Pen market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
Novo Nordisk A/S (Denmark), Becton, Dickinson and Company (US), Ypsomed Holding AG (Switzerland), Sanofi (France), Eli Lilly and Company (US), Merck KGaA (Germany), AstraZeneca plc (UK), F. Hoffmann-La Roche Ltd. (Switzerland), Owen Mumford (UK), Sulzer Ltd. (Switzerland), Sun Pharmaceutical Industries Ltd. (India), Pfizer (US), Biocon Ltd. (India), Lupin Ltd. (India), Wockhardt Ltd. (India), AptarGroup, Inc. (US), Novartis AG (Switzerland), Gerresheimer AG (Germany), Bespak Europe Ltd. (UK), SHL Medical AG (Switzerland), Boehringer Ingelhem (Germany), Nemera France SA, Companion Medical (US), and Jiangsu Delfu Medical Devices Co., Ltd. (China).
Primary Target Market
- Market Players of Injection Pen
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Third-party knowledge providers
- Value-Added Resellers (VARs)
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2031. INFINITIVE DATA EXPERT has segmented the global Injection Pen market based on the below-mentioned segments:
Global Injection Pen Market, By Type
Disposable injection pen
Reusable injection pen
Global Injection Pen market, By Therapy
Growth Hormone
Osteoporosis
Fertility
Others
Diabetes
Global Injection Pen Market, By End User
Home-care Settings
Hospital and clinics
Global Injection Pen market, Regional Analysis
- Europe: Germany, Uk, France, Italy, Spain, Russia, Rest of Europe
- The Asia Pacific: China,Japan,India,South Korea,Australia,Rest of Asia Pacific
- South America: Brazil, Argentina, Rest of South America
- Middle East & Africa: UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa
About This Research
You will get in-depth and extensive injection pen market market research and competitor analysis for your business to help you develop more profound insights into the injection pen market Market.
Through INFINITIVE Data Expert is a professional Market Research services, I will identify the injection pen market market size, demand & opportunities, growth rate, and target audience with a comprehensive analysis of your competitors.